Phase: Phase IIType: DiagnosticAge: 18 and overTrial IDs: 13-C-0193, NCI-2014-02318, 335154, NCT01967537Phase: Phase IIType: Biomarker/Laboratory analysis, DiagnosticAge: 19 and overTrial IDs: NET0017, NCI-2014-01016, 26988, NCI-2014-00101, NCT01980732
